Da li žene iz seoskog područja Srbije ređe sprovode preventivne mere protiv karcinoma grlića materice?
Sažetak
, selo-grad
Uvod/Cilj. U poređenju sa drugim evropskim zemljama, učestalost raka grlića materice u centraloj Srbiji je najviša. Sa standardizovanom stopom mortaliteta od 10,1 na 1000 000 žena, Srbija je na drugom mestu u Evropi. Cilj istraživanja bio je da se ispitaju razlike u primeni mera prevencije raka grlića materice kod žena seoskih i gradskih područja u Srbiji i ustanovi da li su one povezane sa sociodemografskim karakteristikama ispitanica i njihovim seksualnim ponašanjem. Metode. Izvršili smo sekundarnu analizu Nacionalnog istraživanja zdravlja stanovništva Srbije iz 2006. godine sprovedeno na reprezentativnom uzorku populacije, po metodi slučajnog uzorka. U ovom radu analizirane su karakteristike ukupno 5 314 žena starosti od 25 do 64 godine. Rezultati. Ispitanice iz seoske sredine idu ređe nego jednom godišnje na konrolne ginekološke preglede (OR = 0,60 95% CI 0,54–0,68). Manje je ispitanica iz seoskih sredina koje su u poslednjih 12 meseci uradile PAPA test, nego ispitanica iz gradskih sredina (OR = 0,55; 95% CI 0,48–0,64). Ispitanice iz grada ređe idu na PAPA test po savetu lekara, u odnosu na ispitanice sa sela (OR = 0,51 95% CI 0,42–0,62). Zaključak. Žene iz seoskih područja Srbije u povećanom su riziku od raka grlića materice nego žene iz gradskih područja. Nesprovođenje preventivnih mera kod seoskih žena nije posledica njihovog mesta boravka, već nižeg obrazovnog i socioekonomskog statusa.
Reference
Kesić V, Jovićević-Bekić A, Vujnović M. Cervical cancer screening in Serbia. Coll Antropol 2007; 31(Suppl 2): 31−6.
Arbyn M, Primic-Zakelj M, Raifu AO, Grce M, Paraskevaidis E, Diakomanolis E, et al. The burden of cervical cancer in South-East Europe at the beginning of the 21st century. Coll Antro-pol 2007; 31(Suppl 2): 7−10.
Smith JS, Green J, Berrington GA, Appleby P, Peto J, Plummer M, et al. Cervical cancer and use of hormonal contraceptives: a sys-tematic review. Lancet 2003; 361(9364): 1159−67.
Mitrović-Jovanović A, Stanimirović B, Nikolić B, Zamurović M, Perišić Ž, Pantić-Aksentijević S. Intraepithelial neoplasms of the ervix, vagina and vulva. Vojnosanit Pregl 2011; 68(12): 1051−6. (Serbian)
Franceschi S, Plummer M, Clifford G, Sanjose S, Bosch X, Herrero R, et al. Differences in the risk of cervical cancer and human pa-pillomavirus infection by education level. Br J Cancer 2009;101(5): 865−70.
McIntyre-Seltman K, Castle PE, Guido R, Schiffman M, Wheeler CM. Smoking is a risk factor for cervical intraepithelial neoplasia grade 3 among oncogenic human papillomavirus DNA-positive women with equivocal or mildly abnormal cytology. Cancer Epidemiol Biomarkers Prev 2005;14(5):1165−70.
Cothran MM, White JP. Adolescent behavior and sexually transmitted diseases: the dilemma of human papillomavirus. Health Care Women Int 2002; 23(3): 306−19.
Louie KS, de Sanjose S, Diaz M, Castellsague X, Herrero R, Meijer CJ, et al. Early age at first sexual intercourse and early pregnancy are risk factors for cervical cancer in developing countries. Br J Cancer 2009; 100(7): 1191−7.
Jensen KE, Hannibal CG, Nielsen A, Jensen A, Nøhr B, Munk C, et al. . Social inequality and incidence of and survival from cancer of the female genital organs in a population-based study in Denmark. Eur J Cancer 2008; 44(14): 2003−17.
Massad LS, Evans CT, Weber KM, Goderre JL, Hessol NA, Henry D, et al. . Changes in knowledge of cervical cancer prevention and human papillomavirus among women with human immu-nodeficiency virus. Obstet Gynecol 2010; 116(4): 941−7.
Sabates R, Feinstein L. The role of education in the uptake of preventative health care: the case of cervical screening in Brit-ain. Soc Sci Med 2006; 62(12): 2998−3010.
Uysal A, Birsel A. Knowledge about cervical cancer risk factors and pap testing behaviour among Turkish women. Asian Pac J Cancer Prev 2009; 10(3): 345−50.
Hoque M, Hoque E, Kader SB. Evaluation of cervical cancer screening program at a rural community of South Africa. East Afr J Public Health 2008; 5(2): 111−6.
Sherris J, Herdman C, Elias C. Cervical cancer in the developing world. West J Med 2001; 175(4): 231−3.
Markovic M, Kesic V, Topic L, Matejic B. Barriers to cervical can-cer screening: A qualitative study with women in Serbia. Soc Sci Med 2005; 61(12): 2528−35.
Ministry of Health Republic of Serbia. National Health Survey for the population of Republic of Serbia, (without data on Kosovo and Metohia). Basic results. Belgrade: Ministry of Health Republic of Serbia; 2006. (Serbian)
Antic LJ, Djikanovic B, Vukovic D, Matejic B. Factors associated with preventive practices for cervical cancer in women in Ser-bia: Data from the National Population Health Survey in Ser-bia 2006. Health Med 2012; 6(4): 1265−78.
Matejić B, Kesić V, Marković M, Topić L. Communications about cervical cancer between women and gynecologists in Serbia. Int J Public Health 2008; 53(5): 245−51.
Ministry of Health Serbia. Project "Support to the implementation of the National Program", "Serbia against cancer" 2010. Available from: http://www.screeningserbia.rs/sites/default/files/.2011.pdf
Spaczyński M, Nowak-Markwitz E, Januszek-Michalecka L, Karo-wicz-Bilińska A. Women's social conditions and their participa-tion in Cervical Cancer Population Screening Program in Pol-and. Ginekol Pol 2009; 80(11): 833−8. (Polish)
Matejic B, Vukovic D, Pekmezovic T, Kesic V, Markovic M. Deter-minants of preventive health behavior in relation to cervical cancer screening among the female population of Belgrade. Health Educ Res 2010; 26(2): 201−11.
Stanković M, Miljković S, Grbeša G, Višnjić A. General characte-ristics of adolescent sexual behavior: National survey. Srp Arh Celok Lek 2009; 137(7−8): 409−15.
Rasevic M, Sedlecki K. The abortion issue in Serbia. Eur J Con-tracept Reprod Helth Care 2009; 14(6): 385−90.
Abdullah AS, Leung TY. Factors associated with the use of breast and cervical cancer screening services among Chinese women in Hong Kong. Public Health 2001; 115(3): 212−7.
Kovacs A, Dobrossy L, Budai A, Boncz I, Cornides A. The state of organized cervical screening program in Hungary in 2006. Orv Hetil 2007; 148(12): 535−7.
Gustafsson L, Pontén J, Zack M, Adami HO. International inci-dence rates of invasive cervical cancer after introduction of cy-tological screening. Cancer Causes Control 1997; 8(5): 755−63.
American Cancer Society. Detailed Guide: Cervical Cancer. Can Cervical Cancer Be Prevented. 2010. Available from: www.cancer.org [cited 2012 March 14].
Anttila A, Ronco G. Description of the national situation of cervical cancer screening in the member states of the Euro-pean Union. Eur J Cancer 2009; 45(15): 2685−708.
Anttila A, Karsa L, Aasmaa A, Fender M, Patnick J, Rebolj M, et al. Cervical cancer screening policies and coverage in Europe. Eur J Cancer 2009; 45(15): 2649−59.
Vivilaki V, Romanidou A, Theodorakis P, Lionis C. Are health education meetings effective in recruiting women in cervical screening programmes? An innovative and inexpensive inter-vention from the island of Crete. Rural Remote Health 2005; 5(2): 376.
Eaker S, Adami HO, Sparen P. Reasons women do not attend screening for cervical cancer: A population-based study in Sweden. Prev Med 2001; 32(6): 482-91.
Li J, Li L, Ma J, Wei L, Niyazi M, Li C, et al. Knowledge and attitudes about human papillomavirus (HPV) and HPV vac-cines among women living in metropolitan and rural regions of China. Vaccine 2009; 27(8): 1210−5.
